These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38198023)

  • 1. KNSTRN Is a Prognostic Biomarker That Is Correlated with Immune Infiltration in Breast Cancer and Promotes Cell Cycle and Proliferation.
    Zhang W; Xiao Y; Zhou Q; Zhu X; Zhang Y; Xiang Q; Wu S; Song X; Zhao J; Yuan R; Xiao B; Li L
    Biochem Genet; 2024 Jan; ():. PubMed ID: 38198023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of
    Deng P; Zhou R; Zhang J; Cao L
    J Cancer; 2021; 12(11):3239-3248. PubMed ID: 33976733
    [No Abstract]   [Full Text] [Related]  

  • 3. NamiRNA-mediated high expression of KNSTRN correlates with poor prognosis and immune infiltration in hepatocellular carcinoma.
    Jin L; Zhang X; Fan M; Li W; Zhang X
    Contemp Oncol (Pozn); 2023; 27(3):163-175. PubMed ID: 38239867
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhang W; Liao Y; Liu C; Liu L; Zhou X
    Dis Markers; 2023; 2023():6729717. PubMed ID: 36845017
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Deng M; Xiong C; He ZK; Bin Q; Song JZ; Li W; Qin J
    Front Genet; 2022; 13():825901. PubMed ID: 35295953
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Jiang F; Huang X; Yang X; Zhou H; Wang Y
    Front Oncol; 2022; 12():795971. PubMed ID: 35814368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer.
    Xiong Y; Ju L; Yuan L; Chen L; Wang G; Xu H; Peng T; Luo Y; Xiao Y; Wang X
    Oncogene; 2021 Mar; 40(9):1595-1608. PubMed ID: 33452459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas.
    Xiao G; Xu X; Chen Z; Zeng J; Xie J
    Clin Med Insights Oncol; 2023; 17():11795549231199915. PubMed ID: 37744424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CKS2 Overexpression Correlates with Prognosis and Immune Cell Infiltration in Lung Adenocarcinoma: A Comprehensive Study based on Bioinformatics and Experiments.
    Wang Z; Zhang M; Wu Y; Yu Y; Zheng Q; Li J
    J Cancer; 2021; 12(23):6964-6978. PubMed ID: 34729099
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma.
    Zhao H; Lu G
    Front Genet; 2022; 13():905581. PubMed ID: 35754829
    [No Abstract]   [Full Text] [Related]  

  • 15. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 16. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M; Li A; Zhou S; Lv H; Yang W
    J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of HMGB3 and its prognostic value in breast cancer.
    Zhou X; Zhang Q; Liang G; Liang X; Luo B
    Front Oncol; 2022; 12():1048921. PubMed ID: 36620553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of
    Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
    Front Genet; 2022; 13():810292. PubMed ID: 35368661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.